TY - JOUR
T1 - Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils
AU - Cao, Xueyuan
AU - Tsukamoto, Tetsuya
AU - Nozaki, Koji
AU - Shimizu, Nobuyuki
AU - Mizoshita, Tsutomu
AU - Kumagai, Toshiko
AU - Kaminishi, Michio
AU - Tatematsu, Masae
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2004/11
Y1 - 2004/11
N2 - Mongolian gerbils infected with Helicobacter pylori (H. pylori) develop heterotopic proliferative glands (HPGs) in the glandular stomach submucosa. To investigate the effects of H. pylori eradication on cell turnover in HPGs, three antibiotics, lansoprazole, amoxicillin and clarithromycin, were administered at 50 or 75 weeks after inoculation of H. pylori, and the stomachs were excised for histological examination at 1, 2, 4, 8 or 25 weeks thereafter. The HPGs were classified into gastric type (G-type) and others (GI+I-type), which included both pure intestinal (I-type) and gastric-and-intestinal mixed type (GI-type). Apoptosis and cell proliferation were evaluated by means of TUNEL assay and BrdU labeling, respectively. At 8 weeks post-eradication, apoptotic indices were significantly increased in the eradication group (G-type: 2.5%; GI+I-type: 7.2%) compared to the non-eradication group (G-type: 0.6%; GI+I-type: 2.1%: P<0.01), while BrdU labeling indices were significantly decreased (G-type: 1.9%; GI+I-type: 6.8% as compared with 4.3% and 13.2%, respectively, P<0.01 for both). At 25 weeks, the apoptotic indices were similarly higher [G-type: 0.4 (eradication group) vs. 0.2% (non-eradication group); GI+I-type: 5.8 vs. 1.1%, both P< 0.01], and the BrdU labeling indices (G-type: 0.8 vs. 2.2%, P<0.01; GI+I-type: 5.1 vs. 11%, P<0.05) continued to be lower in HPGs. Furthermore, there were highly significant reductions in the areas of HPGs at 8 and 25 weeks post-eradication. These findings demonstrated that eradication results in apoptosis and reduction of proliferation of HPGs in H. pylori-infected gerbils, these lesions thus being apparently reversible through regulation of cell kinetics.
AB - Mongolian gerbils infected with Helicobacter pylori (H. pylori) develop heterotopic proliferative glands (HPGs) in the glandular stomach submucosa. To investigate the effects of H. pylori eradication on cell turnover in HPGs, three antibiotics, lansoprazole, amoxicillin and clarithromycin, were administered at 50 or 75 weeks after inoculation of H. pylori, and the stomachs were excised for histological examination at 1, 2, 4, 8 or 25 weeks thereafter. The HPGs were classified into gastric type (G-type) and others (GI+I-type), which included both pure intestinal (I-type) and gastric-and-intestinal mixed type (GI-type). Apoptosis and cell proliferation were evaluated by means of TUNEL assay and BrdU labeling, respectively. At 8 weeks post-eradication, apoptotic indices were significantly increased in the eradication group (G-type: 2.5%; GI+I-type: 7.2%) compared to the non-eradication group (G-type: 0.6%; GI+I-type: 2.1%: P<0.01), while BrdU labeling indices were significantly decreased (G-type: 1.9%; GI+I-type: 6.8% as compared with 4.3% and 13.2%, respectively, P<0.01 for both). At 25 weeks, the apoptotic indices were similarly higher [G-type: 0.4 (eradication group) vs. 0.2% (non-eradication group); GI+I-type: 5.8 vs. 1.1%, both P< 0.01], and the BrdU labeling indices (G-type: 0.8 vs. 2.2%, P<0.01; GI+I-type: 5.1 vs. 11%, P<0.05) continued to be lower in HPGs. Furthermore, there were highly significant reductions in the areas of HPGs at 8 and 25 weeks post-eradication. These findings demonstrated that eradication results in apoptosis and reduction of proliferation of HPGs in H. pylori-infected gerbils, these lesions thus being apparently reversible through regulation of cell kinetics.
UR - http://www.scopus.com/inward/record.url?scp=11044236951&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=11044236951&partnerID=8YFLogxK
U2 - 10.1111/j.1349-7006.2004.tb02196.x
DO - 10.1111/j.1349-7006.2004.tb02196.x
M3 - Article
C2 - 15546504
AN - SCOPUS:11044236951
SN - 1347-9032
VL - 95
SP - 872
EP - 877
JO - Cancer science
JF - Cancer science
IS - 11
ER -